Literature DB >> 23751272

Physiological and medical findings in insomnia: implications for diagnosis and care.

Michael H Bonnet1, George G Burton2, Donna L Arand2.   

Abstract

This review will examine objective physiological abnormalities and medical comorbidities associated with insomnia and assess the need to measure parameters associated with these abnormalities for diagnosis and to monitor treatment outcomes. Findings are used to develop a decision tree for the work-up of insomnia patients. Currently available measures and those with possible future predictive value will be discussed. Costs, advantages, and the development of screening laboratory tests will be presented. It is concluded that there is a need to differentially evaluate insomnia patients based upon their comorbidities and the presence of objectively decreased total sleep time to direct optimal treatment. The development of objective diagnostic criteria and treatment outcome goals beyond subjective symptomatic relief will establish insomnia as a true medical problem and improve patient care.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depression; Diabetes; Hyperarousal; Hypertension; Insomnia; Pain; Sleep disorders

Mesh:

Year:  2013        PMID: 23751272     DOI: 10.1016/j.smrv.2013.02.003

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  14 in total

1.  The "anti-inflammatory" properties of CBT-I.

Authors:  Simon D Kyle; Kai Spiegelhalder
Journal:  Sleep       Date:  2014-09-01       Impact factor: 5.849

2.  Mechanism of excessive wake time when associated with obstructive sleep apnea or periodic limb movements.

Authors:  Magdy Younes; Eleni Giannouli
Journal:  J Clin Sleep Med       Date:  2020-01-14       Impact factor: 4.062

3.  The nature of stable insomnia phenotypes.

Authors:  Vivek Pillai; Thomas Roth; Christopher L Drake
Journal:  Sleep       Date:  2015-01-01       Impact factor: 5.849

4.  Temporal relations between peripheral and central arousals in good and poor sleepers.

Authors:  Ana Ribeiro; Rachel Gabriel; Bernardo Garcia; Casey Cuccio; William Aqeel; Alejandro Moreno; Colby Landeen; Arlene Hurley; Neil Kavey; Donald Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-13       Impact factor: 12.779

5.  Regional Patterns of Elevated Alpha and High-Frequency Electroencephalographic Activity during Nonrapid Eye Movement Sleep in Chronic Insomnia: A Pilot Study.

Authors:  Brady A Riedner; Michael R Goldstein; David T Plante; Meredith E Rumble; Fabio Ferrarelli; Giulio Tononi; Ruth M Benca
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

6.  Sleep myths: an expert-led study to identify false beliefs about sleep that impinge upon population sleep health practices.

Authors:  Rebecca Robbins; Michael A Grandner; Orfeu M Buxton; Lauren Hale; Daniel J Buysse; Kristen L Knutson; Sanjay R Patel; Wendy M Troxel; Shawn D Youngstedt; Charles A Czeisler; Girardin Jean-Louis
Journal:  Sleep Health       Date:  2019-04-17

7.  Treatment of chronic primary sleep onset insomnia with Kundalini yoga: a randomized controlled trial with active sleep hygiene comparison.

Authors:  Sat Bir S Khalsa; Michael R Goldstein
Journal:  J Clin Sleep Med       Date:  2021-09-01       Impact factor: 4.324

8.  National patterns of physician management of sleep apnea and treatment among patients with hypertension.

Authors:  Rebecca Robbins; Azizi Seixas; Girardin Jean-Louis; Sairam Parthasarathy; David M Rapoport; Gbenga Ogedegbe; Joseph A Ladapo
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

9.  Insomnia symptoms and subclinical myocardial injury: Data from the Nord-Trøndelag Health (HUNT) study.

Authors:  Fjola D Sigurdardottir; Magnus N Lyngbakken; Kristian Hveem; Harald Hrubos Strøm; Helge Røsjø; Susan Redline; Torbjørn Omland
Journal:  J Sleep Res       Date:  2021-02-24       Impact factor: 5.296

10.  Referral Practices for Cognitive Behavioral Therapy for Insomnia: A Survey Study.

Authors:  Deirdre A Conroy; Matthew R Ebben
Journal:  Behav Neurol       Date:  2015-07-21       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.